Pfizer RSV Vaccine That Protects Infants Could Receive FDA Approval This Summer
The single-dose RSV vaccine developed by Pfizer is administered to expectant mothers in the late second-to-third trimester of their pregnancy.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
